Any day now, the first gene editing technologies for medical use will be approved by the FDA. The goal of gene editing is to alter an ailing person’s DNA sequence. Well…Welcome to the brave new world. In the Market Intel segment, we’ll review a Wall Street Journal report on two biotech companies that are at the forefront of the DNA Sequence editing frontier. Then Steve explains why so many retiring professionals are choosing Next Generation Annuities with Guaranteed Income Riders to anchor their retirement. A very timely show you don’t want to miss…MASTERING MONEY is on the air!!!
